Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 06  •  03:16PM ET
24.36
Dollar change
+0.11
Percentage change
0.45
%
Index- P/E17.68 EPS (ttm)1.38 Insider Own0.07% Shs Outstand581.13M Perf Week-8.70%
Market Cap14.16B Forward P/E9.92 EPS next Y2.46 Insider Trans0.00% Shs Float580.70M Perf Month-10.01%
Enterprise Value26.11B PEG0.88 EPS next Q0.57 Inst Own6.38% Short Float0.11% Perf Quarter1.20%
Income807.27M P/S0.65 EPS this Y37.10% Inst Trans0.92% Short Ratio1.81 Perf Half Y-13.22%
Sales21.71B P/B0.93 EPS next Y9.73% ROA2.22% Short Interest0.64M Perf YTD7.60%
Book/sh26.25 P/C9.59 EPS next 5Y20.00% ROE5.31% 52W High30.46 -20.03% Perf Year21.50%
Cash/sh2.54 P/FCF7.12 EPS past 3/5Y-20.26% -14.87% ROIC3.08% 52W Low20.76 17.34% Perf 3Y77.94%
Dividend Est.0.82 (3.38%) EV/EBITDA7.07 Sales past 3/5Y0.15% 1.35% Gross Margin25.02% Volatility2.10% 1.55% Perf 5Y-36.28%
Dividend TTM0.81 (3.35%) EV/Sales1.20 EPS Y/Y TTM13.17% Oper. Margin9.00% ATR (14)0.59 Perf 10Y-45.48%
Dividend Ex-DateMay 23, 2025 Quick Ratio1.00 Sales Y/Y TTM4.09% Profit Margin3.72% RSI (14)29.20 Recom3.06
Dividend Gr. 3/5Y5.17% 2.66% Current Ratio1.36 EPS Q/Q37.84% SMA20-8.44% Beta0.88 Target Price27.36
Payout57.49% Debt/Eq0.81 Sales Q/Q9.16% SMA50-6.34% Rel Volume0.87 Prev Close24.25
Employees113840 LT Debt/Eq0.72 EarningsNov 04 BMO SMA200-5.63% Avg Volume355.90K Price24.36
IPOSep 17, 1996 Option/ShortYes / Yes EPS/Sales Surpr.6.34% -2.33% Trades Volume277,664 Change0.45%
Date Action Analyst Rating Change Price Target Change
Oct-15-25Downgrade BofA Securities Neutral → Underperform
Sep-02-25Downgrade UBS Neutral → Sell
Dec-02-24Upgrade BofA Securities Underperform → Neutral
Nov-06-24Initiated Berenberg Buy $25.60
Jan-08-24Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-24-23Upgrade HSBC Securities Reduce → Hold
Nov-17-23Upgrade Societe Generale Hold → Buy
Aug-14-23Downgrade UBS Buy → Neutral
Aug-01-23Resumed Citigroup Neutral
Jul-12-23Initiated Goldman Buy
Nov-05-25 10:53AM
Nov-04-25 04:01PM
09:58AM
07:00AM
Oct-30-25 09:00AM
08:43AM Loading…
Oct-27-25 08:43AM
Oct-24-25 01:49PM
Oct-16-25 09:40AM
Oct-07-25 11:40AM
Oct-02-25 09:50AM
Oct-01-25 09:35AM
Sep-24-25 09:40AM
Sep-23-25 01:11PM
Sep-18-25 03:30PM
Sep-10-25 09:00AM
04:59PM Loading…
Sep-08-25 04:59PM
Sep-02-25 04:26PM
Aug-19-25 09:40AM
Aug-11-25 12:59PM
07:00AM
Aug-07-25 11:40AM
Aug-06-25 11:01AM
10:39AM
Aug-05-25 10:15AM
07:00AM
01:43AM
01:24AM
Aug-01-25 11:03AM
Jul-31-25 08:30AM
Jul-30-25 09:55AM
11:35AM Loading…
Jul-29-25 11:35AM
11:30AM
09:40AM
08:50AM
Jul-24-25 11:33AM
10:50AM
Jul-21-25 11:40AM
Jul-17-25 11:58AM
Jul-16-25 11:02AM
Jul-11-25 09:40AM
Jul-10-25 12:09PM
Jul-09-25 10:36AM
Jul-08-25 03:54AM
Jul-07-25 09:18AM
Jul-04-25 11:40AM
Jul-03-25 08:00AM
Jul-02-25 11:34AM
Jun-30-25 02:29PM
Jun-25-25 09:40AM
Jun-24-25 08:19AM
Jun-18-25 11:40AM
Jun-17-25 11:33AM
08:56AM
07:00AM
Jun-09-25 09:40AM
Jun-04-25 12:31PM
12:00PM
08:00AM
Jun-02-25 09:50AM
May-30-25 08:00AM
May-27-25 08:24AM
May-22-25 11:45AM
09:40AM
May-15-25 12:00PM
09:50AM
08:06AM
May-09-25 07:08AM
05:44AM
04:36AM
May-08-25 03:08AM
03:08AM
May-07-25 08:09PM
12:30PM
May-06-25 10:25AM
09:40AM
07:00AM
May-05-25 11:09AM
May-02-25 11:05AM
08:30AM
May-01-25 11:46AM
11:34AM
11:32AM
10:40AM
09:13AM
Apr-30-25 11:25AM
Apr-29-25 01:10PM
Apr-28-25 01:18PM
11:24AM
Apr-27-25 05:08AM
Apr-25-25 12:50PM
12:48PM
Apr-24-25 01:02PM
11:36AM
Apr-23-25 12:39PM
09:40AM
Apr-21-25 09:57AM
Apr-17-25 09:40AM
08:50AM
Apr-16-25 09:07AM
06:30AM
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.